Cargando…

Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls

BACKGROUND: Conflicting results have been obtained for the association between two common polymorphisms (C282Y, H63D) of human HFE (hereditary hemochromatosis) gene and the risks of the liver diseases, including non-alcoholic fatty liver disease (NAFLD), liver cirrhosis and hepatocellular carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Qing, Qian, Bao-Xin, Yin, Wei-Li, Wang, Feng-Mei, Han, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033482/
https://www.ncbi.nlm.nih.gov/pubmed/27657935
http://dx.doi.org/10.1371/journal.pone.0163423
_version_ 1782455154985926656
author Ye, Qing
Qian, Bao-Xin
Yin, Wei-Li
Wang, Feng-Mei
Han, Tao
author_facet Ye, Qing
Qian, Bao-Xin
Yin, Wei-Li
Wang, Feng-Mei
Han, Tao
author_sort Ye, Qing
collection PubMed
description BACKGROUND: Conflicting results have been obtained for the association between two common polymorphisms (C282Y, H63D) of human HFE (hereditary hemochromatosis) gene and the risks of the liver diseases, including non-alcoholic fatty liver disease (NAFLD), liver cirrhosis and hepatocellular carcinoma (HCC). METHODS: An updated systematic review and meta-analysis was conducted to evaluate the potential role of HFE polymorphisms in the susceptibility to NAFLD, liver cirrhosis and HCC. After retrieving articles from online databases, eligible studies were enrolled according to the selection criteria. Stata/SE 12.0 software was utilized to perform the statistical analysis. RESULTS: In total, 43 articles with 5,758 cases and 14,741 controls were selected. Compared with the control group, a significantly increased risk of NAFLD was observed for the C282Y polymorphism in the Caucasian population under all genetic models and for the H63D polymorphism under the allele, heterozygote and dominant models (all OR>1, P(association)<0.05). However, no significant difference between liver cirrhosis cases and the control group was observed for HFE C282Y and H63D (all P(association)>0.05). In addition, we found that HFE C282Y was statistically associated with increased HCC susceptibility in the overall population, while H63D increased the odds of developing non-cirrhotic HCC in the African population (all OR>1, P(association)<0.05). Moreover, a positive association between compound heterozygosity for C282Y/H63D and the risk of NAFLD and HCC, but not liver cirrhosis, was observed. CONCLUSION: Our meta-analysis provides evidence that the HFE C282Y and H63D polymorphisms confer increased genetic susceptibility to NAFLD and HCC but not liver cirrhosis. Additional well-powered studies are required to confirm our conclusion.
format Online
Article
Text
id pubmed-5033482
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-50334822016-10-10 Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls Ye, Qing Qian, Bao-Xin Yin, Wei-Li Wang, Feng-Mei Han, Tao PLoS One Research Article BACKGROUND: Conflicting results have been obtained for the association between two common polymorphisms (C282Y, H63D) of human HFE (hereditary hemochromatosis) gene and the risks of the liver diseases, including non-alcoholic fatty liver disease (NAFLD), liver cirrhosis and hepatocellular carcinoma (HCC). METHODS: An updated systematic review and meta-analysis was conducted to evaluate the potential role of HFE polymorphisms in the susceptibility to NAFLD, liver cirrhosis and HCC. After retrieving articles from online databases, eligible studies were enrolled according to the selection criteria. Stata/SE 12.0 software was utilized to perform the statistical analysis. RESULTS: In total, 43 articles with 5,758 cases and 14,741 controls were selected. Compared with the control group, a significantly increased risk of NAFLD was observed for the C282Y polymorphism in the Caucasian population under all genetic models and for the H63D polymorphism under the allele, heterozygote and dominant models (all OR>1, P(association)<0.05). However, no significant difference between liver cirrhosis cases and the control group was observed for HFE C282Y and H63D (all P(association)>0.05). In addition, we found that HFE C282Y was statistically associated with increased HCC susceptibility in the overall population, while H63D increased the odds of developing non-cirrhotic HCC in the African population (all OR>1, P(association)<0.05). Moreover, a positive association between compound heterozygosity for C282Y/H63D and the risk of NAFLD and HCC, but not liver cirrhosis, was observed. CONCLUSION: Our meta-analysis provides evidence that the HFE C282Y and H63D polymorphisms confer increased genetic susceptibility to NAFLD and HCC but not liver cirrhosis. Additional well-powered studies are required to confirm our conclusion. Public Library of Science 2016-09-22 /pmc/articles/PMC5033482/ /pubmed/27657935 http://dx.doi.org/10.1371/journal.pone.0163423 Text en © 2016 Ye et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ye, Qing
Qian, Bao-Xin
Yin, Wei-Li
Wang, Feng-Mei
Han, Tao
Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title_full Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title_fullStr Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title_full_unstemmed Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title_short Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
title_sort association between the hfe c282y, h63d polymorphisms and the risks of non-alcoholic fatty liver disease, liver cirrhosis and hepatocellular carcinoma: an updated systematic review and meta-analysis of 5,758 cases and 14,741 controls
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033482/
https://www.ncbi.nlm.nih.gov/pubmed/27657935
http://dx.doi.org/10.1371/journal.pone.0163423
work_keys_str_mv AT yeqing associationbetweenthehfec282yh63dpolymorphismsandtherisksofnonalcoholicfattyliverdiseaselivercirrhosisandhepatocellularcarcinomaanupdatedsystematicreviewandmetaanalysisof5758casesand14741controls
AT qianbaoxin associationbetweenthehfec282yh63dpolymorphismsandtherisksofnonalcoholicfattyliverdiseaselivercirrhosisandhepatocellularcarcinomaanupdatedsystematicreviewandmetaanalysisof5758casesand14741controls
AT yinweili associationbetweenthehfec282yh63dpolymorphismsandtherisksofnonalcoholicfattyliverdiseaselivercirrhosisandhepatocellularcarcinomaanupdatedsystematicreviewandmetaanalysisof5758casesand14741controls
AT wangfengmei associationbetweenthehfec282yh63dpolymorphismsandtherisksofnonalcoholicfattyliverdiseaselivercirrhosisandhepatocellularcarcinomaanupdatedsystematicreviewandmetaanalysisof5758casesand14741controls
AT hantao associationbetweenthehfec282yh63dpolymorphismsandtherisksofnonalcoholicfattyliverdiseaselivercirrhosisandhepatocellularcarcinomaanupdatedsystematicreviewandmetaanalysisof5758casesand14741controls